Core Viewpoint - The company, Shanwaishan (688410.SH), is expected to achieve a significant increase in net profit for the year 2025, indicating strong financial growth driven by its leading position in the blood purification equipment market [1] Financial Performance - The projected net profit attributable to the parent company's shareholders for 2025 is estimated to be between 140.35 million and 159.49 million yuan, representing a year-on-year increase of 98% to 125% [1] - The net profit attributable to the parent company after deducting non-recurring gains and losses is expected to be between 134.37 million and 154.38 million yuan, reflecting a year-on-year increase of 135% to 170% [1] Market Position - The company is recognized as a leading player in the domestic blood purification equipment sector, benefiting from technological advantages and strong brand recognition [1] - The continuous increase in market share has contributed to the steady growth of sales revenue for blood purification equipment [1]
山外山(688410.SH):预计2025年净利润同比增加98%到125%